GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Market Cap

2cureX AB (OSTO:2CUREX) Market Cap : kr6.18 Mil (As of May. 17, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 2cureX AB's share price for the quarter that ended in Sep. 2023 was kr3.24. 2cureX AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 17.60 Mil. Therefore, 2cureX AB's market cap for the quarter that ended in Sep. 2023 was kr57.03 Mil.

2cureX AB's quarterly market cap declined from Mar. 2023 (kr113.19 Mil) to Jun. 2023 (kr72.35 Mil) and declined from Jun. 2023 (kr72.35 Mil) to Sep. 2023 (kr57.03 Mil).

2cureX AB's annual market cap increased from Dec. 2020 (kr245.88 Mil) to Dec. 2021 (kr293.59 Mil) but then declined from Dec. 2021 (kr293.59 Mil) to Dec. 2022 (kr143.46 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 2cureX AB's Enterprise Value for Today is kr-11.93 Mil.


2cureX AB Market Cap Historical Data

The historical data trend for 2cureX AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Market Cap Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial 147.21 169.53 245.88 293.59 143.46

2cureX AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 165.82 143.46 113.19 72.35 57.03

Competitive Comparison of 2cureX AB's Market Cap

For the Biotechnology subindustry, 2cureX AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Market Cap distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Market Cap falls into.



2cureX AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

2cureX AB's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=kr8.15*17.6029
=kr143.46

2cureX AB's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=kr3.24*17.6029
=kr57.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


2cureX AB  (OSTO:2CUREX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


2cureX AB Market Cap Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


2cureX AB (OSTO:2CUREX) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines